Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Biotechnology Innovation Organization

Trade Association · Registrant & Client

Reviewed by LobbySpend Editorial Team · Updated
C
Influence Score
59/100
Moderate Influence
$11.9M
Total Lobby Spend
5
Policy Issues
8
Lobbyists
3
Revolving Door

Biotechnology Innovation Organization's Federal Lobbying Record

At $11.9M in disclosed federal lobbying, Biotechnology Innovation Organization ranks as a major spender — well above the typical filer. Outlays in this range generally reflect a sustained presence in Washington, with at least one full-time government affairs lead and a stable of outside lobbyists engaged on the organization's priority issues.

Across the 5-year window from 2020 to 2024, Biotechnology Innovation Organization's annual disclosed lobbying spend has declined modestly — from $2.6M in 2020 to $2.3M in 2024, a change of -14%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.

Biotechnology Innovation Organization's disclosed lobbying covers 5 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.

3 of 8 lobbyists reported by Biotechnology Innovation Organization (38%) disclose prior federal government service. That share is common at established government affairs operations that explicitly hire from agency and committee staff.

Among the named bench, lobbyists with disclosed prior federal service include Robert L. Walker (Former Counsel, Senate Commerce Committee); Margaret A. Nelson (Former Legislative Assistant, U.S. Senate); Kenneth L. Lewis (Former Counsel, House Financial Services Committee). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.

Within the Trade Association sector, Biotechnology Innovation Organization ranks #10 of 114 tracked organizations by disclosed lobbying spend. The sector leader is US Chamber of Commerce at $387.8M; the sector average is $9.5M. Biotechnology Innovation Organization's $11.9M sits 25% above the sector average.

Biotechnology Innovation Organization's LobbySpend Influence Score of 59/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.

Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.

Track Biotechnology Innovation Organization's lobbying filings

Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Justice
Securities & Exchange Commission
Office of the U.S. Trade Representative
Centers for Medicare & Medicaid Services
Office of Management & Budget
Federal Communications Commission
U.S. Senate
Dept of Defense

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecBiotechnology Innovation Organization
PHAHCR
4$640K
2024 Jul-SepBiotechnology Innovation Organization
CPTPHASCI
4$602K
2024 Apr-JunBiotechnology Innovation Organization
HCRCPTPHA+2
4$506K
2024 Jan-MarBiotechnology Innovation Organization
SCIHCRCPT
2$475K
2023 Oct-DecBiotechnology Innovation Organization
PHACPTHCR
2$508K
2023 Jul-SepBiotechnology Innovation Organization
HCRPHACPT+2
2$468K
2023 Apr-JunBiotechnology Innovation Organization
SCIGOVCPT
4$496K
2023 Jan-MarBiotechnology Innovation Organization
GOVPHASCI
2$491K

Biotechnology Innovation Organization Lobbying FAQ

Biotechnology Innovation Organization has spent $11.9M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Biotechnology Innovation Organization lobbies on 5 policy issues, including Health Issues, Pharmacy, Science/Technology, Copyright/Patent/Trademark. These disclosures are filed quarterly with the Senate Office of Public Records.

Biotechnology Innovation Organization has an Influence Score of 59/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Biotechnology Innovation Organization employs 8 registered lobbyists, of whom 3 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Biotechnology Innovation Organization has contacted 8 government entities as part of their lobbying activities, including Dept of Justice, Securities & Exchange Commission, Office of the U.S. Trade Representative.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.